Top compounds associated with response to PRAMEF18


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.043 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.043 0.2
mRNA SN-38 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA PX-12 CTRPv2 pan-cancer AAC -0.036 0.2
mRNA Tamoxifen CTRPv2 pan-cancer AAC -0.047 0.2
mRNA phloretin CTRPv2 pan-cancer AAC 0.043 0.2
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.2
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA CI-976 CTRPv2 pan-cancer AAC -0.048 0.2
Download CSV